Do you usually hold Fosamax (alendronate) before dental work?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Fosamax Before Dental Work

You do not routinely need to hold Fosamax (alendronate) before most dental procedures, but you should complete a comprehensive dental evaluation and necessary invasive dental work before starting bisphosphonate therapy whenever possible. 1, 2

Pre-Treatment Dental Assessment (Ideal Scenario)

  • Complete all necessary invasive dental procedures before initiating Fosamax, as this eliminates the osteonecrosis of the jaw (ONJ) risk entirely 2, 3
  • Perform a comprehensive dental evaluation of both hard and soft tissues, including radiographic examination, before starting bisphosphonate therapy 1, 3
  • Treat all active oral infections and eliminate high-risk sites before bisphosphonate initiation 2
  • Correct vitamin D deficiency prior to bisphosphonate therapy to avoid hypocalcemia 1, 2

Risk Stratification for ONJ

The risk of ONJ with oral Fosamax is extremely low compared to intravenous bisphosphonates used in cancer treatment:

  • Oral bisphosphonates for osteoporosis: <1 case per 100,000 person-years 1, 2
  • Intravenous bisphosphonates for cancer: 6.7-11% incidence 2
  • The most consistent risk factor is recent dental surgery or extraction 1, 2

Management When Dental Work is Needed During Treatment

The Drug Holiday Controversy

The evidence regarding stopping Fosamax before dental procedures remains controversial and lacks strong support:

  • Some experts hypothesize that stopping bisphosphonates 2 months prior to oral surgery may allow better bone healing, with resumption delayed until adequate healing occurs 1, 2, 3
  • However, the alternative view is that a short break in bisphosphonate administration will have no effect, as bone effects of bisphosphonates are maintained for years after treatment stops 1
  • The decision to discontinue therapy must balance the risk of ONJ against the risk of fractures that might occur during the drug holiday 3

Practical Approach for Routine Extractions

For patients already on oral Fosamax requiring tooth extraction, the procedure can be performed safely without stopping the medication:

  • A prospective study of 1,480 extractions in 700 patients on oral bisphosphonates showed 100% success with zero cases of ONJ using atraumatic surgical technique 4
  • Use prophylactic antibiotics perioperatively 2, 3
  • Employ atraumatic surgical technique with minimal trauma to soft and hard tissues 4
  • Ensure complete mucosal healing before resuming normal activities 3

Ongoing Dental Care During Treatment

  • Maintain excellent oral hygiene and receive regular dental check-ups every 6 months 2, 3
  • Inform your dental practitioner of your bisphosphonate treatment 1, 2
  • Avoid elective invasive dental procedures (implants, complex extractions) when possible during active therapy 3
  • Schedule post-procedure follow-up every 6-8 weeks until complete mucosal healing has occurred 3

Critical Caveats

  • The fracture prevention benefits of continued Fosamax therapy in osteoporosis patients generally outweigh the minimal ONJ risk, especially when proper dental protocols are followed 2
  • Patients with suspected ONJ should be referred to a dental practitioner or oral surgeon with expertise in treating this condition 1, 2
  • Risk of ONJ increases with frequency, dose, and duration of bisphosphonate administration 1, 2
  • Concurrent chemotherapy, corticosteroid use, poor oral hygiene, and pre-existing dental infections increase ONJ risk 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bisphosphonate Discontinuation and Osteonecrosis of the Jaw Risk

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Bisphosphonate Therapy in Dental Procedures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Tooth extraction in osteoporotic patients taking oral bisphosphonates.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.